Understanding the Negative Effects of Social Isolation

Last updated: November 2026.

The most effective treatment for bipolar disorder is usually a combination of medication and psychotherapy, matched to the phase of the illness and continued over the long term. That's the answer most people are looking for, and it is supported by the reviews cited here. According to the National Institute of Mental Health (NIMH), bipolar disorder "usually requires lifelong treatment," but an effective plan helps people manage symptoms and improve their quality of life. A 2013 review in The Lancet by Geddes and Miklowitz organizes the evidence the same way: medication for acute episodes and prevention, with psychological treatment added on top. If you or someone you love was just diagnosed, or just went through a relapse, this guide walks through what each part does and why it matters. You can also read how we approach bipolar disorder treatment at Amae.

What "effective" means when you have bipolar disorder

Treatment has two jobs. The first is ending a current episode, whether that's mania, hypomania, depression, or an episode with mixed features (symptoms of both poles at once). The second, and the one that shapes the years ahead, is preventing the next episode.

Those jobs don't always call for the same tools. A medication that calms acute mania may not be the choice for bipolar depression, and the plan that works during a crisis often changes once mood settles. That's why the American Academy of Family Physicians (AAFP) review from 2021 splits treatment into acute mania, mixed features, acute depression, and maintenance. So when people ask about the best treatment for bipolar disorder, the real reply starts with a question back: best for which phase?

First-line treatment for bipolar disorder: medication by phase

Medication is the base of treatment for most people with bipolar disorder. The main classes are:

• Mood stabilizers, including lithium and certain anticonvulsants. NIMH notes that some anticonvulsants work better than lithium for certain people, such as those with mixed symptoms or rapid cycling.
• Atypical antipsychotics, used for mania, mixed episodes, and in some cases bipolar depression or maintenance.
• Antidepressants, typically given alongside a mood stabilizer because of the risk of switching into mania.

The AAFP review describes mood stabilizers, including lithium, anticonvulsants, and antipsychotics, as a first-line treatment that "should be continued indefinitely because of the risk of patient relapse." Drug-by-drug detail, side effects, and pregnancy considerations are covered in our guide to how mood stabilizers work.

Treating a manic or mixed episode

Acute mania usually needs urgent care. The AAFP review says patients with acute mania require hospitalization because of the risk of harm to themselves or others, and that early goals include adequate sleep and reducing psychotic symptoms; high-quality evidence supports mood stabilizers, including lithium, valproic acid, and antipsychotics. For mixed features, the same review says antidepressants on their own are contraindicated.

Treating bipolar depression

Bipolar depression isn't treated the way Major Depressive Disorder is. An antidepressant on its own can tip some people into mania. For bipolar depression, NIMH says health care providers typically prescribe a mood stabilizer and an antidepressant together to reduce the risk of switching into mania. Some atypical antipsychotics are also used in this phase.

Long-term maintenance

This is where many plans fall apart. People feel well, the medication feels unnecessary, and they stop. Bipolar disorder is a relapsing illness: the AAFP review reports relapse in more than 70% of patients within five years, whatever the treatment, which is why it recommends continuing medication indefinitely. Any change to medication belongs in a conversation with the prescriber, never a quiet decision at home.

Lithium has the longest track record for maintenance. NIMH states that "some studies indicate that lithium may reduce the risk of suicide" among people taking it for long-term maintenance, and that people on lithium need regular monitoring of lithium levels and kidney and thyroid function.

When first options do not work

Some people don't respond to the first or second medication plan. Clinicians then adjust doses, combine medications, or look at other treatments. One of these is electroconvulsive therapy (ECT): the AAFP review states that ECT is effective for mania and psychotic depression. We include it here for education, not as a service we provide.

Therapies that work alongside medication

Medication steadies mood. Therapy builds the skills and routines that keep it steady. The main evidence-based options:

• Psychoeducation teaches you and your family how the illness behaves, which early signs to watch, and what to do when they show up.
• Cognitive behavioral therapy (CBT) works on the thoughts and habits that feed depressive episodes and on catching early warning signs.
• Family-focused therapy brings relatives in to improve communication and plan for relapses together.
• Interpersonal and social rhythm therapy (IPSRT) stabilizes daily rhythms, especially sleep, meals, and social contact, which are closely tied to mood shifts.

Supportive therapy, a steady relationship with a clinician for problem-solving and encouragement, is also widely used alongside these.

The numbers here are encouraging. A 2021 JAMA Psychiatry review by Miklowitz and colleagues pooled 39 randomized trials with 3,863 participants. Structured psychotherapy added to medication was associated with fewer recurrences than medication plus a control treatment, and family or group psychoeducation did better than individual psychoeducation. For a closer look at each approach, see our guide to supportive therapy for bipolar disorder.

Can bipolar disorder be treated without medication?

Short answer: the research supports therapy and routine changes added to medication, not in place of it. Every trial in the 2021 JAMA Psychiatry review compared medication plus psychotherapy with medication plus a control treatment. None tested therapy alone as a replacement.

That doesn't make the non-medication side minor. It's where much of the day-to-day work happens. As part of a full treatment plan, these habits help:

• Regular sleep and wake times. AAFP lists sleep hygiene among active lifestyle approaches and names circadian disruption, such as shift work, as an environmental trigger.
• Avoiding alcohol and drugs. Alcohol and drugs such as cocaine can trigger manic symptoms, and AAFP lists substance use among the things to monitor in ongoing care.
• Tracking early warning signs. A simple mood and sleep log can show a shift days before it becomes an episode.
• Managing stress. Psychosocial stress is a known trigger of both manic and depressive symptoms, according to AAFP.
• Keeping a daily rhythm. Consistent meals, activity, and social contact are the backbone of IPSRT.

If you're thinking about reducing or stopping medication, talk it through with your psychiatrist first. NIMH advises against stopping a prescribed medication without your provider's help, even if you feel better; a provider can lower the dose slowly and safely.

Bipolar I vs. bipolar II: does the most effective treatment differ?

Bipolar I Disorder involves at least one manic episode, which can include psychosis. Bipolar II Disorder involves hypomania, a milder elevated state, along with major depressive episodes. In bipolar II, depression is often what people live with most.

The core principles are shared: medication matched to the phase, therapy added on top, and long-term follow-up. The choices shift with which episodes dominate. AAFP notes that antidepressant monotherapy is contraindicated in bipolar I, mania, and mixed episodes, so the medication conversation looks a little different for each type. Some conditions can look similar to bipolar disorder at first glance; our article on BPD vs. bipolar explains one common source of confusion.

What makes treatment work over the long term

The right medication and the right therapy only work if the plan holds together over years. Over the long term, a few practical things make a large difference:

• Staying in treatment. AAFP lists treatment adherence among the core parts of ongoing management. Side effects, cost, or simply feeling better are all common reasons people stop, and each one is worth raising with the care team.
• Watching physical health. Some medications affect the body as well as mood. NIMH notes that people taking atypical antipsychotics may need regular monitoring of weight, glucose, and lipid levels, and lithium requires blood tests.
• One plan, not three. When the psychiatrist, therapist, and primary care doctor share information, side effects get caught and changes don't conflict.
• Bringing family in. Relatives often notice an early shift before the person does. The evidence for family psychoeducation points the same way.

When weekly appointments are not enough

Outpatient care, with a psychiatrist and therapist seen every week or few weeks, works for many people. But not during a hard stretch. An IOP (Intensive Outpatient Program) adds several hours of structured treatment a few days a week while you live at home. A PHP (Partial Hospitalization Program) is more intensive, with treatment most of the day on most weekdays. Inpatient care is for times when safety can't be maintained at home. Learn how our intensive outpatient program and partial hospitalization program work, or compare them in PHP vs. IOP.

When to seek help now

Some signs mean an episode may be starting and the care team should hear about it soon. NIMH lists symptoms such as a decreased need for sleep, racing thoughts, and an excessive appetite for pleasurable activities. Others point the other way: sleeping too much and a lack of interest in almost all activities.

Thoughts of self-harm or suicide need help the same day. If you or someone you love is in crisis, call or text 988, or see the FAQ below.

How we treat bipolar disorder at Amae Health

Bipolar disorder is one of the conditions we specialize in at Amae Health. We treat adults 18 and older with severe mental illness (SMI) in in-person outpatient clinics, with care led by psychiatrists. Your team works under one roof: psychiatrists, therapists, primary care physicians, dietitians, health coaches, peer mentors, and clinical care coordinators, all on one treatment plan. When more structure is needed, we offer PHP and IOP. Our tagline, Beyond Care. Towards Cure., means aiming for remission and recovery, not stopping at stability.

To start, see bipolar disorder treatment at Amae or call 1-888-860-2825. When you call, it helps to have a list of your current medications and past treatments ready.

Key takeaways

• The most effective treatment for bipolar disorder is usually medication plus psychotherapy, continued long term.
• Treatment depends on the phase: acute mania, bipolar depression, and maintenance each call for different choices.
• Antidepressants are typically given alongside a mood stabilizer, not on their own.
• Therapy and daily routines work best added to medication, not as a replacement.
• Staying in treatment, monitoring physical health, and stepping up the level of care when needed keep a plan working.

Frequently Asked Questions

What is the most effective treatment for bipolar disorder?

For most people, it's a combination of medication and psychotherapy, adjusted to the phase of illness and continued over the long term. NIMH notes that bipolar disorder usually requires lifelong treatment. Therapy added to medication is linked to fewer recurrences.

What is the first-line treatment for bipolar disorder?

Mood stabilizers, such as lithium and certain anticonvulsants, and some atypical antipsychotics. The choice depends on whether the person is in a manic, mixed, or depressive episode, or in maintenance. A psychiatrist weighs the phase, history, and side effects.

What is the most effective treatment for bipolar 2?

The same principles apply: medication, therapy, and long-term follow-up. Depression is often the main focus in bipolar II. Antidepressants are typically prescribed together with a mood stabilizer to reduce the risk of switching into mania.

Is it possible to recover from bipolar disorder?

Bipolar disorder is a long-term condition, but many people reach long periods of stability with ongoing treatment. Recovery here means fewer and milder episodes and a life that works on your terms. Staying in treatment is what protects that.

What is a good daily routine for someone with bipolar disorder?

Regular sleep and wake times, consistent meals, daily activity, and a simple mood log. This idea is at the center of interpersonal and social rhythm therapy. A routine supports treatment; it doesn't replace it.

What should I do if someone with bipolar disorder is in crisis?

Call or text 988 to reach the 988 Suicide and Crisis Lifeline, available 24/7. If someone is in immediate danger, call 911. Stay with the person if it's safe to do so.

Finishing a course of TMS and feeling like yourself again brings a new worry: will it hold? How long do TMS results last, and what happens if the depression comes back? The research is more encouraging than many people expect. Among people who respond to a course, roughly half to nearly two-thirds are still responding a year later, and when symptoms do return, restarting TMS brought back the improvement for most people in the research.

‍

None of that predicts any one person's course. It does show what tends to help results last, and why the months after treatment deserve a plan of their own.

What "Lasting" Means: Response vs. Remission

Two terms do most of the work in durability research. A person has responded when their depression scores fall by at least half on a standard rating scale. They're in remission when scores drop low enough that the depression is largely gone.

‍

Durability studies then ask a narrower question than the original trials did: of the people who responded or reached remission by the end of a course, how many were still doing well months later? That framing matters when you read the numbers. A result such as 62.5% of people keeping their response for a year describes people who had already responded, not everyone who started TMS. Those follow-up checks happen at set points, typically three, six, and 12 months after a course, so durability is reported as the share of people still responding at each checkpoint.

What the Research Shows About Durability

The most direct data come from a 2014 study in The Journal of Clinical Psychiatry that followed people with medication-resistant major depression for a year after they finished TMS at 42 U.S. clinical practices. Of the 257 people who completed a course and agreed to follow-up, 120 had responded or reached remission by the end of treatment. Of those 120, 75 (62.5%) kept meeting response criteria through the full 12 months.

‍

Two details shape that result. The study used a practical approach after the course: continued antidepressant medication, plus access to more TMS if symptoms returned. And over the year, 93 participants (36.2%) had TMS reintroduced at some point, averaging about 16 treatment days. So the 62.5% reflects TMS inside ongoing care, not a single course left to stand on its own.

‍

A 2019 meta-analysis in Brain Stimulation pooled 19 studies of people who had responded to a TMS course. About two-thirds were still responding at three months, about 53% at six months, and about 46% at one year. The authors' summary: roughly half of responders keep their response for up to a year after a successful course.

‍

Read together, the two studies give a realistic range of around half to nearly two-thirds of responders still doing well a year out. The other side of those numbers matters just as much. A meaningful share of people see symptoms return within the first year, and planning for that possibility is part of good care, not a sign that treatment failed.

Factors That Influence How Long Results Last

The research has identified a few patterns, mostly at the level of groups rather than individuals:

‍

• Maintenance treatment. In the 2019 meta-analysis, studies that included maintenance treatment showed higher sustained response at some time points.
• The mix of people studied. Studies with a higher proportion of women also showed higher sustained response, a group-level pattern that says nothing reliable about any one person.
• Continued medication. The best-known durability results come from people who stayed on antidepressants after TMS, so those numbers describe that combination.
• A completed course. Durability figures come from people who finished a full acute course. They don't describe what happens after a partial one.

‍

Clinicians also weigh a person's history when planning follow-up, such as how many depressive episodes they've had and how many treatments failed before TMS. The findings above don't establish how much those factors change the odds, so they inform a clinician's judgment rather than supply a number.

Maintenance TMS: What It Is and Who May Need It

TMS maintenance treatment means periodic sessions after the main course, scheduled to protect a response rather than to answer a relapse. Schedules vary between providers and between people, and no single schedule has become standard.

‍

The evidence supports the idea without settling the details. The 2019 meta-analysis found maintenance associated with more durable response, and its authors suggested maintenance be considered in practice and tested in future trials. That's a promising signal, not a proven protocol. Maintenance TMS is also separate from staying on medication: in both the year-long and six-month studies, people continued antidepressants whether or not they received more TMS.

‍

Not everyone needs it. Some people stay well for long stretches without it. Whether maintenance makes sense for a particular person is a judgment a psychiatrist makes from their history and how they're doing in the months after the course.

Can TMS Be Repeated If Symptoms Return?

Yes, and the research on restarting TMS is among the most reassuring parts of this topic. In a six-month study in Brain Stimulation, people whose depression had improved by at least a quarter with TMS stopped treatment gradually over three weeks while starting maintenance antidepressant medication. In that study, worsening had a specific meaning: a clinician-rated decline that held for two consecutive weeks, which triggered restarting TMS. Over the next 24 weeks, 38% had symptoms worsen enough to restart TMS, and 32 of those 38 people (84%) regained their improvement. Only 10% of the 99 people whose results were reported met the study's definition of relapse.

‍

A repeat course is different from maintenance. Maintenance is planned in advance to hold a response; a repeat course starts because symptoms have come back. In the year-long study described above, about a third of participants had TMS reintroduced at some point. Whether and when to restart is a decision made with a psychiatrist, based on how symptoms are changing.

What Helps Results Last Longer

Beyond maintenance and continued medication, two more things help, though neither promises that results will last for a particular person:

‍

• Catching changes early. In the six-month study, regular assessments flagged worsening symptoms, and most people who restarted TMS at that point regained their improvement.
• Staying connected to care. Therapy and regular psychiatric visits mean someone is watching for early changes between treatments.

‍

Knowing what returning depression tends to look like makes early changes easier to catch: shifts in sleep or appetite, lower energy, less interest in usual activities, and a low mood that lingers instead of lifting after a few days. When those signs show up, reaching out sooner gives a care team more options, and our guide on how to ask for help when depressed covers how to start that conversation.

‍

These describe what research associates with better long-term results in groups of patients. They aren't instructions for any one person's treatment plan; that's a psychiatrist's call, made with the whole history in view.

Talking to a Psychiatrist About a Long-Term Plan

A TMS course is the start of a plan, not the end of one. The months afterward are when follow-up, medication decisions, and a clear plan for what happens if symptoms return matter most.

‍

At Amae, TMS sits inside our integrated care model, where psychiatric care, therapy, primary care, and peer support stay linked after the course ends. We provide TMS therapy for major depressive disorder at our Los Angeles clinic and at our Bay Area clinics in Los Altos and San Mateo. Commercial insurance plans and cash pay are both accepted, and our intake team handles prior authorization. To map out what comes after a course, talk with an Amae psychiatrist about a long-term plan. Anyone in crisis can reach the 988 Suicide and Crisis Lifeline by call or text.

Frequently Asked Questions

How long do TMS results typically last?

For many people, months to a year or longer, though it varies. In a year-long study of people who responded to TMS, 62.5% kept meeting response criteria for the full 12 months. A 2019 meta-analysis found that about half of responders were still responding at one year.

What percentage of people relapse after TMS?

Some return of symptoms within a year is common. In the 2019 meta-analysis, roughly half of responders were no longer responding at one year. That isn't always a full relapse: in a six-month study, 38% had symptoms worsen enough to restart TMS, while 10% met the study's definition of relapse.

Can TMS be repeated if depression comes back?

Yes. In a six-month study, 84% of people whose symptoms worsened regained their improvement when TMS was restarted. A repeat course is different from ongoing maintenance sessions, and the decision is made with a psychiatrist based on individual history.

Do I need maintenance TMS sessions after my initial course?

Not necessarily. Some people stay well without them, and there is no standard maintenance schedule across providers. Research links maintenance with longer-lasting response, so whether it fits is a decision a psychiatrist makes based on your response and how closely symptoms are being monitored.

What can help TMS results last longer?

The research points to planned follow-up, continued medication when it's part of the plan, and catching symptom changes early. These are general findings from groups of patients, not instructions for any one person's treatment.

Is maintenance TMS covered by insurance?

It depends on the insurer and on whether sessions are billed as maintenance or as a new course for returning symptoms, since coverage can differ between the two. Ask the provider to verify benefits with your insurer before sessions begin.

‍

Citations

1. Dunner DL, Aaronson ST, Sackeim HA, et al. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. Journal of Clinical Psychiatry. 2014;75(12):1394-1401. https://pubmed.ncbi.nlm.nih.gov/25271871/
2. Senova S, Cotovio G, Pascual-Leone A, Oliveira-Maia AJ. Durability of antidepressant response to repetitive transcranial magnetic stimulation: systematic review and meta-analysis. Brain Stimulation. 2019;12(1):119-128. https://pubmed.ncbi.nlm.nih.gov/30344109/
3. Janicak PG, Nahas Z, Lisanby SH, et al. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimulation. 2010;3(4):187-199. https://pubmed.ncbi.nlm.nih.gov/20965447/
4. 988 Suicide and Crisis Lifeline. https://988lifeline.org

‍

TMS is not shock therapy. That is the first thing to settle in any TMS vs ECT comparison, because that phrase, and all the baggage that comes with it, refers to electroconvulsive therapy (ECT), not transcranial magnetic stimulation. TMS uses magnetic pulses, involves no anesthesia and no seizure, and you drive yourself home afterward. Both are evidence-based brain stimulation treatments for depression, and both work. They differ substantially in how they work, what the treatment is like to go through, and who they are typically used for. Knowing the difference between TMS and ECT is what lets you and your psychiatrist match the treatment to the situation.

What Is TMS?

Transcranial magnetic stimulation delivers focused magnetic pulses through a coil resting on the scalp to a specific region of the brain, usually the left dorsolateral prefrontal cortex, which is involved in mood regulation. The stimulation is targeted to that one site rather than generalized across the brain, and because it stimulates a small area without inducing a seizure, the procedure needs no anesthesia and takes place in an ordinary clinic or office, as the National Institute of Mental Health describes. FDA clearance came in 2008 for major depressive disorder, with obsessive-compulsive disorder added in 2018.

‍

At our clinics, a standard course of TMS therapy is 20 to 30 sessions, one per weekday, 30 to 40 minutes each, over about four to six weeks, and you sit awake in a chair for every one of them. No seizure is induced, nothing enters your bloodstream, and when the session ends you can drive yourself home and return to your day.

What Is ECT?

Electroconvulsive therapy is a controlled medical procedure performed under general anesthesia. You are given a short-acting anesthetic and an intravenous muscle relaxant to prevent movement, and electrodes on the scalp deliver a brief electrical current that produces seizure activity in the brain lasting under a minute. You wake within minutes, recover over the following hour or so, and need someone to take you home. A typical course is three sessions a week until symptoms improve, usually within 6 to 12 treatments.

‍

ECT is one of the oldest treatments in psychiatry and one of the most effective for severe depression. The FDA's clearance covers catatonia and severe depressive episodes in people age 13 and older with major depression or bipolar disorder who have not responded to other treatments or need a rapid response, and it is also used for mania and for certain presentations of schizophrenia and schizoaffective disorder. It is most often reserved for situations where fast, powerful relief matters: acute suicidality, depression with psychotic features, or catatonia.

‍

The stigma around ECT comes from portrayals that are decades out of date, from an era before anesthesia and muscle relaxants were used. Modern ECT is delivered in a monitored setting by a full medical team, and its main drawback is not what those old images suggest. It is the effect on memory, covered below.

TMS vs ECT: Side-by-Side Comparison

Effectiveness: What the Research Shows

Both treatments work. In head-to-head trials of electroconvulsive therapy vs TMS, ECT comes out ahead. A 2014 systematic review and meta-analysis in Depression Research and Treatment pooled nine randomized clinical trials comparing the two, with 384 participants in total. Both groups improved significantly. On the Hamilton Depression Rating Scale, the standard clinician-rated measure, scores fell by an average of 15.4 points with ECT and 9.3 points with TMS, a statistically significant difference (P = 0.011). The author concluded that ECT produced larger reductions in depressive symptoms, while the results also supported the therapeutic validity of TMS for people with treatment-resistant depression.

‍

A few things keep that finding in proportion. The trials were conducted between 2000 and 2011, largely with early TMS protocols. And "more effective" is not the same as "the right choice." Real-world TMS outcomes come from a different population. In naturalistic data from 42 U.S. clinics, 58% of outpatients with medication-resistant depression responded to a standard course and 37% reached remission. For someone whose depression has resisted medication but who is stable enough for outpatient care, that is the relevant number.

‍

In the head-to-head studies that exist, ECT delivers stronger short-term symptom reduction. TMS delivers a meaningful effect without anesthesia, without a hospital, and without the recovery and memory considerations described next.

Side Effects and Memory Concerns

Memory is the question people bring to this comparison more than any other, and it deserves a direct answer.

‍

ECT is associated with memory effects, particularly for events around the time of treatment. NIMH describes memory loss close to the treatment period that is sometimes more severe but usually improves over the days and weeks after the course ends, alongside headaches, upset stomach, muscle aches, and short-lived confusion. The largest analysis of the question, a 2010 meta-analysis in Biological Psychiatry covering 84 studies and 2,981 patients, found that measurable cognitive effects were mainly limited to the first three days after treatment. By 4 to 15 days, nearly all measures had recovered, and after 15 days processing speed, working memory, new learning, and some aspects of executive function had improved beyond where they were before treatment, most likely because the depression itself had lifted. Some people do report longer-lasting gaps in personal memories from the months around treatment, and that possibility belongs in the conversation before ECT.

‍

TMS carries no known negative effect on memory or thinking, and it requires no anesthesia. Its side effects are local: discomfort where the coil sits, tingling or twitching of scalp or facial muscles during the pulses, mild headache, and occasional brief lightheadedness. Those usually fade within the first week. Seizure is the one serious risk, and it is exceedingly rare. Screening for seizure history, metal in the head, and implanted devices is what keeps it that way.

What to Expect: The Treatment Experience

The daily reality of the two treatments could not be more different.

‍

A TMS session is a 30-to-40-minute appointment. You sit in a chair, awake, while the coil delivers pulses that feel like tapping on the scalp. When it ends, you stand up, get in your car, and go on with your day, then repeat tomorrow. There is no downtime and no preparation beyond an initial screening visit.

‍

An ECT session is a medical procedure. You fast beforehand, an IV is placed, and you are under anesthesia for a few minutes while the treatment is delivered in a hospital or specialized clinic with an anesthesia provider and a psychiatrist present. You wake up groggy, spend time in recovery, and need someone to take you home. Over several sessions a week for several weeks, that is a real commitment from you and whoever supports you, and ECT is sometimes delivered during an inpatient stay rather than as an outpatient.

Who Is Each Treatment Typically Recommended For?

These are different tools for different clinical pictures, not simply a better and a worse option.

‍

ECT is typically recommended when depression is severe, acute, or urgent, and the speed of response matters: someone at high risk of suicide, someone with psychotic depression, someone with catatonia, or someone who has not responded to multiple treatments. The trade-off of anesthesia and memory effects is accepted because the alternative is worse, and for anyone in that situation care for suicidal thoughts comes first.

‍

TMS is typically recommended for moderate or treatment-resistant depression in someone who is stable enough for outpatient care and can attend daily sessions, when there is no need for the fastest possible response. It is often the next step after antidepressants have failed and before ECT would be considered. For that person, a treatment without anesthesia, without memory effects, and without disruption to work or family life has real value, even if its average effect size is smaller.

Talking to a Psychiatrist About Your Options

Choosing between TMS and ECT is a clinical decision, made with a psychiatrist, that turns on three things: how severe your depression is, how urgently it needs to change, and what you have already tried. It is not a decision to make from a comparison table alone, including this one.

‍

At Amae, we offer TMS at our Los Angeles, Los Altos, and San Mateo clinics as part of our integrated outpatient clinics, where psychiatry, therapy, primary care, and peer support come from one team. We do not offer ECT. If our psychiatrists conclude that ECT is the better clinical fit for you, they will say so and help coordinate a referral, because the goal is the right treatment, not the treatment we happen to provide. If you are trying to work out where you stand, talk with an Amae psychiatrist. And if you are having thoughts of suicide right now, call or text 988, the Suicide and Crisis Lifeline.

Frequently Asked Questions

Is TMS the same as ECT?

No, and it is not "shock therapy" either. That phrase refers to ECT. TMS uses magnetic pulses targeted to one region of the brain, with no anesthesia and no seizure, and you stay awake and drive yourself home. ECT uses electrical stimulation to produce a brief, controlled seizure under general anesthesia in a monitored medical setting.

Does TMS cause memory loss like ECT can?

No. TMS has no known negative effect on memory or thinking; its side effects are scalp discomfort and headache, both short-lived and usually gone within a week. ECT can cause memory loss around the time of treatment that typically improves over the weeks after the course ends.

Which is more effective, TMS or ECT?

In head-to-head research, ECT produces larger short-term symptom reductions. A 2014 meta-analysis of nine randomized trials found average Hamilton scale drops of 15.4 points with ECT versus 9.3 with TMS, with both treatments producing significant improvement. TMS remains a well-supported outpatient option without anesthesia or recovery time, so "more effective" is not the same as "right for your situation."

Is ECT still used today?

Yes. ECT remains a well-established, evidence-based treatment, typically used for severe, urgent, psychotic, or catatonic depression and for depression that has not responded to other treatments. The stigma around it comes from decades-old portrayals that do not resemble modern practice.

Can you drive yourself home after TMS or ECT?

After TMS, yes. There is no anesthesia or sedation, so people typically drive themselves home and return to their day immediately. After ECT, no. General anesthesia means you need a support person to take you home and some recovery time before normal activities.

Does Amae Health offer ECT?

No. We offer TMS at our Los Angeles, Los Altos, and San Mateo clinics as part of integrated psychiatric care. We do not offer ECT, and if a psychiatrist concludes that ECT is the better fit for your situation, we help coordinate a referral to a provider who does.

‍

Citations

1. Micallef-Trigona B. Comparing the effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in the treatment of depression: a systematic review and meta-analysis. Depression Research and Treatment. 2014. https://pubmed.ncbi.nlm.nih.gov/25143831/
2. National Institute of Mental Health. Brain Stimulation Therapies. https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies
3. Semkovska M, McLoughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biological Psychiatry. 2010. https://pubmed.ncbi.nlm.nih.gov/20673880/
4. Carpenter LL, Janicak PG, Aaronson ST, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depression and Anxiety. 2012. https://pubmed.ncbi.nlm.nih.gov/22689344/
5. 988 Suicide and Crisis Lifeline. https://988lifeline.org

‍